Clinical Trial Update: Long Term Extension Study For SPM-005 Participants [Phase 1, Phase 2]

View source ↗

Summary

A long-term extension study update for SPM-005 in rheumatoid arthritis, covering Phase 1 and Phase 2 participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SPM-005

Snippet

Sponsor: SetPoint Medical Corporation | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: UNKNOWN